Cardinal Health (NYSE: CAH), Dublin, OH, reported sales for the fiscal 2018 third quarter of $33.6 billion, a 6 percent increase over the prior-year period.

Sales in the company’s Pharmaceuticals segment increased 5 percent to $29.7 billion due to sales growth from pharmaceutical and specialty distribution customers. Segment profit decreased by 3 percent to $596 million.

Third-quarter revenue for the Medical segment increased 15 percent to $3.9 billion, driven primarily by the acquisition of the Patient Recovery business. Segment profit increased 34 percent to $199 million, driven by contributions from acquisitions.